APSR2026-769

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP10-023
P23
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1213453-46904-ASPR-AP10-023_440177.pdf
Format: PDF Only
07. COPD
1

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

shanmuga priya kumar * sri lalithambigai medical college and hospital respiratory medicine chennai India
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
shanmuga priya
kumar
pshanmuga75@yahoo.com
+919677229629
31-40
India
Original Research
Comparative Effectiveness of Aerobika and Acapella OPEP Devices on Pulmonary Function and Quality of Life in COPD Patients
Maximum 25 words
Abstract Content
Chronic Obstructive Pulmonary Disease (COPD) is associated with airflow limitation, mucus retention, and reduced quality of life. Oscillatory Positive Expiratory Pressure (OPEP) devices such as Aerobika and Acapella are commonly used for airway clearance, but comparative evidence is limited.
A comparative interventional study was conducted among 40 COPD patients, divided into Aerobika (n=20) and Acapella (n=20) groups. Both groups received standard respiratory therapy along with OPEP device training. Outcomes assessed included spirometry (FEV₁, FVC, FEV₁/FVC), 6-minute walk distance (6MWD), Borg dyspnea scale, and St. George’s Respiratory Questionnaire (SGRQ). Pre- and post-intervention data were analyzed using paired t-tests and Wilcoxon tests.
Significant improvements were observed in both groups (p < 0.001). Mean FEV₁ improved from 37.0% to 45.8%, FVC from 45.8% to 56.0%, and FEV₁/FVC ratio from 65.2% to 76.8%. 6MWD increased from 242.3 m to 307.5 m. SGRQ scores decreased from 55.1 to 28.1, indicating improved quality of life. Dyspnea scores improved with a shift from Borg scale 5–7 to 1–2. The Aerobika group showed slightly greater improvements compared to Acapella.
Both Aerobika and Acapella devices significantly improve pulmonary function, exercise capacity, and quality of life in COPD patients. Aerobika demonstrated slightly superior outcomes and may be preferred in patients with increased mucus retention.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
COPD, Aerobika, Acapella, OPEP, Pulmonary Function, 6MWD, SGRQ
maximum 3 keywords and no abbreviations, separated by commas
The authors declare no conflicts of interest.No external funding was received for this study.
220